Healthcare provider profile · identity verified

Chuyi He, M.D.

Family Practice · FONTANA, CA · NPI 1396272183

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	422	174
Amlodipine Besylate	Amlodipine Besylate	404	137
Losartan Potassium	Losartan Potassium	295	100
Levothyroxine Sodium	Levothyroxine Sodium	177	56
Lisinopril	Lisinopril	150	60
Albuterol Sulfate Hfa	Albuterol Sulfate	119	66
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	119	34
Fluticasone Propionate	Fluticasone Propionate	118	67
Pantoprazole Sodium	Pantoprazole Sodium	103	35
Metoprolol Tartrate	Metoprolol Tartrate	102	30
Hydrochlorothiazide	Hydrochlorothiazide	101	45
Atenolol	Atenolol	94	33
Famotidine	Famotidine	93	43
Gabapentin	Gabapentin	90	38
Alendronate Sodium	Alendronate Sodium	87	33
Metformin Hcl Er	Metformin Hcl	76	34
Tamsulosin Hcl	Tamsulosin Hcl	72	26
Metformin Hcl	Metformin Hcl	69	26
Trazodone Hcl	Trazodone Hcl	66	27
Glipizide	Glipizide	65	23
Simvastatin	Simvastatin	64	22
Allopurinol	Allopurinol	55	24
Alvesco	Ciclesonide	49	24
Breyna	Budesonide/Formoterol Fumarate	49	20
Metoprolol Succinate	Metoprolol Succinate	49	16
Hydralazine Hcl	Hydralazine Hcl	47	16
Pravastatin Sodium	Pravastatin Sodium	47	16
Lovastatin	Lovastatin	46	17
Furosemide	Furosemide	43	24
Montelukast Sodium	Montelukast Sodium	43	20
Fluoxetine Hcl	Fluoxetine Hcl	39	13
Oxycodone Hcl	Oxycodone Hcl	37	11
Prednisone	Prednisone	37	21
Rosuvastatin Calcium	Rosuvastatin Calcium	37	15
Bisoprolol Fumarate	Bisoprolol Fumarate	36	12
Ibuprofen	Ibuprofen	36	20
Spiriva Respimat	Tiotropium Bromide	35	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	14
Finasteride	Finasteride	32	12
Hydrocortisone	Hydrocortisone	31	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	14
Potassium Chloride	Potassium Chloride	30	13
Tramadol Hcl	Tramadol Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	21
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	20
Topiramate	Topiramate	26	suppressed
Mupirocin	Mupirocin	25	12
Omeprazole	Omeprazole	23	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Spironolactone	Spironolactone	23	12
Carvedilol	Carvedilol	22	suppressed
Colchicine	Colchicine	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Ozempic	Semaglutide	22	suppressed
Cefadroxil	Cefadroxil	21	18
Cefpodoxime Proxetil	Cefpodoxime Proxetil	21	18
Clonazepam	Clonazepam	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	12
Acyclovir	Acyclovir	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Baclofen	Baclofen	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Nystatin	Nystatin	18	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lorazepam	Lorazepam	17	12
Sertraline Hcl	Sertraline Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Azithromycin	Azithromycin	15	12
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	14	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Naproxen	Naproxen	12	suppressed
Lactulose	Lactulose	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error